ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6,701 | 33.72998 | 0 | female | 0 | 9 | 1,321 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 35,602 | 24,688.875 | 25,589.0469 | 13 | black | 20.898438 | 12 | 0.878906 | 0.835938 | 22 | 0 | 0 | no | 1 | 1 | no dnr | 9 | 95 | 5 | 104 | 24 | 37.69531 | 253.03125 | 2 | 1.099854 | 0.699951 | 133 | 7.40918 | null | null | null | 4 | 2 | no(M2 and SIP pres) | 2 |
6,702 | 57.71399 | 1 | female | 0 | 21 | 31 | MOSF w/Malig | ARF/MOSF | 4 | 11 | under $11k | 9 | 22,480 | 14,848.2656 | 18,645.4375 | 25 | black | 17.398438 | 20 | 0.744995 | 0.665894 | 1 | 1 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 8 | 89 | 40.09375 | 96 | 24 | 39.59375 | 261.875 | 2.599609 | 0.5 | 1.099854 | 141 | 7.489258 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
6,703 | 70.40094 | 1 | male | 0 | 6 | 307 | CHF | COPD/CHF/Cirrhosis | 4 | 8 | $11-$25k | 0 | 4,826 | 3,220.4199 | 3,311.68945 | 6 | white | 15.798828 | 25 | 0.887939 | 0.81189 | 1 | 0 | 0 | no | 0.53 | 0.3 | dnr after sadm | 2 | 108 | 7.599609 | 74 | 22 | 36.29688 | 380.9375 | 3.599609 | 1 | 1.599854 | 140 | 7.5 | null | null | null | null | null | null | 2.507813 |
6,704 | 26.26099 | 1 | male | 1 | 4 | 4 | Coma | Coma | 4 | null | null | 0 | 11,013 | 7,114.2812 | 7,941.80859 | 70 | black | 46 | 68 | 0.473999 | 0.40094 | 1 | 1 | 0 | no | 0.2 | 0.2 | dnr after sadm | 4 | 41 | 11.699219 | 0 | 46 | 39.09375 | 167.5 | 2.5 | 0.899902 | 1.699951 | 143 | 7.199219 | null | null | null | null | null | <2 mo. follow-up | 2.440918 |
6,705 | 70.79297 | 1 | male | 0 | 5 | 668 | CHF | COPD/CHF/Cirrhosis | 5 | 12 | under $11k | 0 | 3,689 | 2,464.5469 | 2,637.85938 | 7 | white | 13.798828 | 22 | 0.902954 | 0.836914 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 107 | 5.899414 | 53 | 22 | 35.69531 | null | 4.399414 | 0.699951 | 1.399902 | 141 | 7.419922 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
6,706 | 63.56998 | 1 | male | 0 | 44 | 227 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 44 | 126,224 | 82,239.625 | 91,960.5 | 42.5 | white | 25 | 24 | 0.602905 | 0.495972 | 4 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 44 | 118 | 17.796875 | 136 | 8 | 39.19531 | 190 | 2 | 1.399902 | 1.199951 | 150 | 7.40918 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,707 | 52.29797 | 1 | male | 1 | 25 | 25 | MOSF w/Malig | ARF/MOSF | 1 | 14 | $25-$50k | 0 | 108,667 | 69,016.75 | 82,232.3125 | 57 | white | 30.597656 | 53 | 0.537964 | 0.422974 | 2 | 0 | 0 | yes | 0.7 | 0.5 | no dnr | 25 | 57 | 22.597656 | 136 | 32 | 39.19531 | 131.09375 | 2.399902 | 0.699951 | 1.099854 | 147 | 7.569336 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
6,708 | 50.10797 | 1 | female | 0 | 20 | 448 | MOSF w/Malig | ARF/MOSF | 1 | 13 | $11-$25k | 9 | 59,953 | 32,717.1094 | 41,005.7812 | 30.333328 | white | 28.597656 | 35 | 0.469971 | 0.35199 | 14 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 20 | 74 | 0 | 101 | 20 | 35.79688 | null | 2.599609 | 0.5 | 0.899902 | 133 | null | null | null | null | 0 | 0 | SIP>=30 | 0 |
6,709 | 40.57999 | 0 | male | 0 | 61 | 1,316 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 9 | 173,158 | 116,037.625 | 131,353.25 | 54 | white | 35.195313 | 66 | 0.637939 | 0.536987 | 4 | 0 | 0 | no | 0.05 | 0.000125 | no dnr | 61 | 60 | 12 | 132 | 14 | 38.39844 | 108 | 1.699951 | 2.899902 | 4.799805 | 142 | 7.279297 | null | null | null | null | 1 | SIP>=30 | 1 |
6,710 | 53.823 | 1 | female | 0 | 8 | 68 | MOSF w/Malig | ARF/MOSF | 1 | 12 | under $11k | 0 | 15,461 | 9,543.1797 | 11,886.4141 | 13 | white | 25.699219 | 25 | 0.532959 | 0.417969 | 7 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 8 | 89 | 0.699951 | 101 | 20 | 36.69531 | null | null | null | 0.899902 | 135 | null | null | null | null | 1 | 1 | null | 1 |
6,711 | 74.22894 | 1 | male | 0 | 13 | 118 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | $11-$25k | 0 | 15,964 | 9,384.25 | 10,116.2891 | 20 | white | 24.199219 | 31 | 0.770996 | 0.696899 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 13 | 77 | 9.898438 | 107 | 28 | 36.29688 | 276.625 | 2.5 | 1.699951 | 1.399902 | 131 | 7.479492 | null | null | null | 3 | 6 | null | 6 |
6,712 | 76.61096 | 1 | male | 0 | 3 | 160 | CHF | COPD/CHF/Cirrhosis | 3 | null | under $11k | 0 | 2,487 | 1,572.0332 | 1,814.7998 | 11 | black | 17.699219 | 31 | 0.851929 | 0.755981 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 62 | 5.399414 | 110 | 20 | 36.39844 | 376.1875 | null | 1.199951 | 1.299805 | 138 | 7.529297 | null | null | null | null | null | null | 2.544922 |
6,713 | 49.28699 | 1 | male | 1 | 28 | 28 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 0 | 86,797 | 55,757.6562 | 64,130.4375 | 45.25 | white | 26.5 | 50 | 0.765991 | 0.690918 | 14 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 28 | 115 | 34.09375 | 140 | 28 | 38 | 347.5625 | 2.399902 | 3.399902 | 0.5 | 137 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 3.225098 |
6,714 | 69.37994 | 1 | female | 0 | 7 | 55 | CHF | COPD/CHF/Cirrhosis | 2 | 13 | null | 0 | 10,879 | 5,274.4727 | 6,358.31641 | 18 | white | 29.699219 | 36 | 0.557983 | 0.362 | 1 | 0 | 0 | metastatic | 0.8 | 0.8 | no dnr | 7 | 59 | 5.5 | 136 | 22 | 36.59375 | null | 2.5 | 1.5 | 1.199951 | 130 | null | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
6,715 | 70.88599 | 1 | male | 0 | 7 | 793 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 6,045 | 3,868.6758 | 4,133.01953 | 9.5 | white | 17.796875 | 17 | 0.861938 | 0.770996 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 7 | 94 | 17.597656 | 118 | 24 | 36.59375 | 280 | 4 | 1 | 1 | 136 | 7.369141 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
6,716 | 62.59299 | 1 | male | 1 | 36 | 36 | Cirrhosis | COPD/CHF/Cirrhosis | 7 | 10 | $11-$25k | 9 | 119,264 | 76,845 | 88,983.75 | 48.25 | white | 25.699219 | 50 | 0.569946 | 0.375 | 5 | 1 | 0 | no | 0.7 | 0.6 | dnr after sadm | 32 | 120 | 20.5 | 61 | 33 | 36 | 257.125 | 2.199707 | 3.099609 | 1.299805 | 129 | 7.399414 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
6,717 | 36.98297 | 1 | male | 0 | 24 | 60 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 26,586 | 17,302.4688 | 18,924.75 | 17 | black | 33.59375 | 35 | 0.737915 | 0.588989 | 6 | 0 | 0 | no | 0.5 | 0.3 | no dnr | 24 | 73 | null | 107 | 28 | 35.89844 | 280 | 2.399902 | 2.399902 | 1.299805 | 127 | 7.449219 | null | null | null | 0 | 0 | SIP>=30 | 0 |
6,718 | 52.19199 | 1 | female | 0 | 6 | 179 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 5,321 | 3,410.6738 | 4,506.80859 | 10 | white | 18.898438 | 5 | 0.814941 | 0.601929 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | no dnr | 6 | 86 | 8.5 | 59 | 20 | 36.5 | null | 3.299805 | 1 | 0.799927 | 136 | null | null | null | null | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
6,719 | 70.46997 | 1 | female | 0 | 38 | 100 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 9 | 94,955 | 62,118.1562 | 68,680.4375 | 38.5 | white | 37.5 | 52 | 0.334961 | 0.218994 | 12 | 0 | 0 | no | 1 | 1 | no dnr | 38 | 50 | 29.296875 | 80 | 10 | 36.39844 | 115.54688 | 1.699951 | 6.899414 | 0.599976 | 135 | 7.429688 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,720 | 78.80597 | 1 | male | 1 | 15 | 15 | MOSF w/Malig | ARF/MOSF | 1 | 6 | under $11k | 9 | 15,662 | 10,750.6406 | 13,315.3125 | 10.333328 | black | 23.296875 | 39 | 0.588989 | 0.47998 | 1 | 0 | 0 | metastatic | 0.4 | 0.2 | dnr after sadm | 1 | 66 | 17.5 | 71 | 20 | 35.89844 | 523.75 | 2.5 | 1.599854 | 2.299805 | 142 | 7.459961 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
6,721 | 71.78894 | 1 | male | 0 | 38 | 937 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 9 | under $11k | 26 | 91,348 | 59,310.0625 | 68,936.5625 | 50.25 | white | 31.796875 | 38 | 0.511963 | 0.394958 | 1 | 0 | 0 | no | 0.4 | 0.4 | no dnr | 38 | 82 | 24.199219 | 106 | 15 | 38.09375 | 91.25 | 2.5 | 1.5 | 2.5 | 144 | 7.369141 | null | null | null | null | 6 | no(M2 and SIP pres) | 6 |
6,722 | 34.875 | 1 | male | 1 | 14 | 14 | MOSF w/Malig | ARF/MOSF | 2 | 0 | under $11k | 0 | 59,218 | 37,512 | 42,662.9375 | 56.666657 | white | 44.398438 | 67 | 0.161987 | 0.079987 | 3 | 0 | 0 | yes | 0.6 | 0.5 | no dnr | 14 | 51 | 2.199707 | 160 | 28 | 35.89844 | 123.75 | 2.299805 | 1.5 | 0.699951 | 132 | 7.419922 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,723 | 78.97095 | 1 | female | 0 | 4 | 30 | MOSF w/Malig | ARF/MOSF | 2 | 12 | under $11k | 0 | 5,415 | 2,838.0508 | 3,703.69922 | 24 | black | 19.398438 | 22 | 0.677979 | 0.583984 | 3 | 0 | 0 | metastatic | 0.3 | 0.2 | no dnr | 4 | 101 | 9.798828 | 76 | 22 | 36.09375 | null | null | null | 1.199951 | 129 | null | null | null | null | 0 | 1 | <2 mo. follow-up | 1 |
6,724 | 62.74298 | 0 | female | 0 | 6 | 1,302 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 6 | under $11k | 0 | 7,487 | 4,930.6758 | 5,606.25781 | 10 | black | 22.097656 | 39 | 0.827881 | 0.768921 | 2 | 1 | 0 | no | 0.95 | 0.8 | no dnr | 6 | 132 | 11.798828 | 96 | 24 | 36.69531 | 252.375 | null | 0.399963 | 2.399902 | 136 | 7.329102 | null | null | null | 2 | 1 | SIP>=30 | 1 |
6,725 | 84.112 | 1 | male | 0 | 30 | 274 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | under $11k | 0 | 25,533 | 16,575.125 | 18,047.8594 | 17.75 | white | 34.59375 | 59 | 0.481995 | 0.363953 | 1 | 0 | 1 | no | 0.5 | 0.4 | dnr after sadm | 2 | 61 | 3.199707 | 138 | 36 | 39 | 191.40625 | 2 | 1.099854 | 2.5 | 150 | 7.329102 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
6,726 | 59.23898 | 1 | female | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 1 | 15 | $25-$50k | 55 | 5,891 | 3,676.1289 | 4,643.15625 | 13 | white | 30.296875 | 32 | 0.156982 | 0.076996 | 3 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 1 | 63 | 19.296875 | 122 | 24 | 37.79688 | null | null | null | 1.699951 | 122 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,727 | 53.465 | 1 | male | 0 | 4 | 225 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 5,590 | 3,078.4727 | 3,631.16992 | 12 | black | 17.796875 | 27 | 0.907959 | 0.845947 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 4 | 71 | 9.398438 | 71 | 22 | 35.89844 | 152 | 4.199219 | 0.599976 | 1.599854 | 138 | 7.099609 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
6,728 | 47.439 | 1 | female | 0 | 11 | 323 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 10 | under $11k | 0 | 14,155 | 9,264.0078 | 11,179.9141 | 15 | white | 30.597656 | 37 | 0.682983 | 0.514893 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 11 | 104 | 17.296875 | 113 | 20 | 36.19531 | 566.625 | 2.599609 | 12 | 0.5 | 144 | 7.489258 | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
6,729 | 41.91898 | 1 | male | 1 | 24 | 24 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 16 | under $11k | 0 | 49,526 | 31,816.1719 | 39,600.2812 | 21.333328 | black | 28.398438 | 43 | 0.763916 | 0.625 | 1 | 0 | 0 | no | 0.8 | 0.75 | dnr after sadm | 19 | 76 | 3.799805 | 69 | 20 | 36 | null | 1.699951 | 25.296875 | 0.5 | 135 | null | null | null | null | 3 | 4 | <2 mo. follow-up | 4 |
6,730 | 71.04395 | 1 | female | 1 | 8 | 8 | Coma | Coma | 3 | 12 | $25-$50k | 100 | 39,241 | 25,236.375 | 28,353.5625 | 35 | white | 18.097656 | 16 | 0.128998 | 0.081985 | 17 | 0 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 3 | 62 | 10.5 | 65 | 10 | 38.59375 | 346.625 | 2.699707 | 0.299988 | 1.099854 | 166 | 7.399414 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
6,731 | 77.55194 | 1 | male | 1 | 163 | 163 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 9 | 265,926 | 177,235.25 | 215,599.375 | 41.5 | white | 22.898438 | 51 | 0.75293 | 0.674927 | 1 | 1 | 0 | no | 0.8 | 0.8 | dnr after sadm | 146 | 155 | 17.898438 | 125 | 28 | 38.89844 | 226.65625 | 2.199707 | 0.799927 | 1.5 | 137 | 7.429688 | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
6,732 | 57.25699 | 1 | male | 0 | 3 | 230 | Colon Cancer | Cancer | 2 | 7 | under $11k | 0 | 2,124 | 1,498.0596 | 1,994.92969 | null | black | 9 | 5 | 0.907959 | 0.786987 | 1 | 0 | 0 | metastatic | 0.2 | 0 | dnr after sadm | 2 | 95 | 10.5 | 58 | 24 | 37.5 | null | null | 0.799927 | 0.799927 | 138 | null | 107 | 6 | 940 | null | 0 | adl>=4 (>=5 if sur) | 0 |
6,733 | 61.84 | 0 | female | 0 | 11 | 1,090 | COPD | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 12,300 | 8,202.9453 | 8,763.98438 | 17 | black | 18.199219 | 23 | 0.866943 | 0.778931 | 1 | 0 | 0 | yes | 0.9 | 0.89 | no dnr | 11 | 65 | 9.5 | 105 | 28 | 38.09375 | 137.5 | null | null | 2 | 137 | 7.419922 | 126 | 29 | 4,955 | 0 | 0 | no(M2 and SIP pres) | 0 |
6,734 | 67.31 | 1 | female | 1 | 22 | 22 | MOSF w/Malig | ARF/MOSF | 1 | 16 | $25-$50k | 0 | 18,881 | 13,809.0859 | 18,162.3125 | 21 | white | 26.398438 | 37 | 0.569946 | 0.458984 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 17 | 83 | 5.5 | 100 | 18 | 36.69531 | 274.0625 | null | 0.399963 | 0.699951 | 137 | 7.389648 | 242 | 10 | null | 1 | 2 | <2 mo. follow-up | 2 |
6,735 | 25.43199 | 0 | female | 0 | 98 | 1,088 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 277,810 | 175,246.125 | 201,567.375 | 42.25 | white | 27 | 45 | 0.880981 | 0.837891 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 98 | 48 | 3.899902 | 115 | 12 | 35.59375 | 388 | 2.599609 | 1.5 | 9.798828 | 126 | 7.449219 | 205 | 56 | 0 | null | 0 | adl>=4 (>=5 if sur) | 0 |
6,736 | 50.19598 | 1 | male | 1 | 13 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 9 | under $11k | 0 | 41,359 | 25,705.0625 | 31,246.625 | 35.5 | white | 42.398438 | 83 | 0.48999 | 0.371948 | 1 | 0 | 0 | no | 0.4 | 0.35 | dnr after sadm | 4 | 83 | 7.799805 | 74 | 24 | 36.79688 | null | 3 | 0.599976 | 0.799927 | 141 | null | 106 | 11 | null | null | 0 | <2 mo. follow-up | 0 |
6,737 | 77.21295 | 1 | male | 0 | 5 | 434 | CHF | COPD/CHF/Cirrhosis | 2 | null | under $11k | 0 | 4,117 | 2,907.9648 | 2,851.25977 | 12 | white | 16.898438 | 34 | 0.858887 | 0.767944 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 5 | 121 | 14.599609 | 74 | 20 | 36.09375 | null | 3.599609 | 0.399963 | 0.699951 | 140 | null | 73 | 7 | 2,310 | 0 | 0 | no(M2 and SIP pres) | 0 |
6,738 | 72.20795 | 1 | female | 1 | 6 | 6 | Coma | Coma | 1 | 14 | under $11k | 100 | 5,676 | 3,781.8262 | 4,726.1875 | 19 | white | 26.199219 | 57 | 0.097992 | 0.058998 | 1 | 1 | 0 | no | 0.05 | 0.05 | dnr after sadm | 1 | 122 | 26.5 | 125 | 8 | 38.09375 | 304 | null | 15.199219 | 8.599609 | 139 | 7.359375 | 166 | 78 | 0 | null | 0 | <2 mo. follow-up | 0 |
6,739 | 79.10699 | 1 | male | 0 | 6 | 403 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | null | 0 | 6,479 | 4,432.9688 | 5,499.58984 | 12 | white | 20.296875 | 31 | 0.812988 | 0.695923 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 6 | 68 | 21.699219 | 145 | 25 | 35.5 | 445 | 1.899902 | 0.799927 | 3.799805 | 135 | 7.229492 | 151 | 54 | 1,850 | 0 | 0 | no(M2 and SIP pres) | 0 |
6,740 | 61.78198 | 0 | male | 0 | 18 | 1,085 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 0 | 30,163 | 17,284.2656 | 20,559.4062 | 23.333328 | white | 40.398438 | 53 | 0.404968 | 0.28595 | 4 | 1 | 0 | no | 0.05 | 0.01 | dnr after sadm | 1 | 63 | 10.599609 | 71 | 28 | 36 | 195 | null | 1.199951 | 1.899902 | 147 | 7.379883 | 106 | 41 | 1,020 | 1 | null | null | 1.166748 |
6,741 | 51.34299 | 1 | male | 0 | 9 | 493 | COPD | COPD/CHF/Cirrhosis | 1 | 0 | under $11k | 0 | 10,785 | 6,678.9844 | 7,258.19922 | 12.5 | white | 27.597656 | 22 | 0.845947 | 0.746948 | 1 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 9 | 127 | 19.796875 | 120 | 10 | 37.79688 | 171.40625 | null | 0.599976 | 1.199951 | 144 | 7.319336 | 260 | 35 | 1,720 | 0 | null | SIP>=30 | 0.494751 |
6,742 | 79.93994 | 1 | male | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 12 | null | 0 | 34,382 | 21,277.8281 | 24,930.6719 | 48.5 | white | 36.59375 | 69 | 0.363953 | 0.246979 | 1 | 0 | 1 | yes | 0.4 | 0.2 | dnr after sadm | 7 | 55 | 14.398438 | 60 | 34 | 38.79688 | 237.125 | 2 | null | 1.099854 | 130 | 7.379883 | 251 | 17 | 480 | null | 7 | <2 mo. follow-up | 7 |
6,743 | 54.853 | 1 | female | 1 | 14 | 14 | MOSF w/Malig | ARF/MOSF | 4 | 12 | >$50k | 0 | 53,156 | 32,901.25 | 43,947.2188 | 49 | white | 28 | 46 | 0.549927 | 0.435974 | 1 | 0 | 0 | metastatic | 0.4 | 0.4 | dnr after sadm | 11 | 113 | 20.699219 | 75 | 11 | 38.79688 | 290 | null | null | 6.5 | 132 | 7.389648 | 85 | 44 | 230 | null | 2 | <2 mo. follow-up | 2 |
6,744 | 58.349 | 0 | female | 0 | 9 | 1,080 | CHF | COPD/CHF/Cirrhosis | 4 | 9 | under $11k | 0 | 7,481 | 5,456.5703 | 6,411.69922 | 11.5 | white | 16.898438 | 21 | 0.904907 | 0.839966 | 1 | 1 | 0 | no | 0.9 | 0.7 | no dnr | 9 | 102 | 11.099609 | 125 | 52 | 39.59375 | 152 | null | 0.699951 | 0.699951 | 131 | 7.419922 | 178 | 31 | 770 | 2 | 1 | no(M2 and SIP pres) | 1 |
6,745 | 34.44199 | 0 | male | 0 | 20 | 1,079 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 15 | null | 9 | 38,032 | 20,595.1406 | 26,019.5156 | 32.333313 | white | 24.898438 | 26 | 0.86499 | 0.817993 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 20 | 65 | 8.699219 | 95 | 29 | 38.39844 | 159.15625 | null | null | 3.5 | 136 | 7.30957 | 151 | 77 | 1,920 | null | 0 | adl>=4 (>=5 if sur) | 0 |
6,746 | 60.64899 | 1 | female | 0 | 7 | 92 | COPD | COPD/CHF/Cirrhosis | 4 | 8 | $11-$25k | 0 | 6,610 | 4,424.2109 | 4,562.78906 | 3 | white | 17.398438 | 21 | 0.878906 | 0.797974 | 1 | 1 | 0 | yes | 0.9 | 0.8 | no dnr | 7 | 0 | 12.199219 | 0 | 0 | 36.09375 | 157 | null | null | 0.899902 | 143 | 7.239258 | 141 | 15 | 3,040 | 4 | null | no(M2 and SIP pres) | 3.183106 |
6,747 | 73.98199 | 1 | male | 1 | 4 | 4 | COPD | COPD/CHF/Cirrhosis | 3 | null | under $11k | 41 | 9,644 | 6,020.7266 | 6,879.83984 | 66 | white | 59.898438 | 85 | 0 | 0 | 1 | 0 | 0 | no | null | null | dnr after sadm | 3 | 53 | 21.296875 | 110 | 36 | 36.19531 | 205 | null | null | 2.199707 | 139 | 7.349609 | 144 | 35 | 425 | null | null | <2 mo. follow-up | 3.58252 |
6,748 | 43.98898 | 0 | male | 0 | 14 | 1,079 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 14 | under $11k | 0 | 15,008 | 10,454.0859 | 12,681.0234 | 10 | white | 27.097656 | 32 | 0.771973 | 0.636963 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 14 | 102 | 6.5 | 70 | 12 | 38.09375 | 266.625 | null | null | 0.599976 | 135 | 7.459961 | 103 | 7 | 5,570 | 3 | null | no(M2 and SIP pres) | 2.510742 |
6,749 | 34.56799 | 0 | female | 0 | 19 | 1,077 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 0 | null | 0 | 57,730 | 36,738.7188 | 40,708.375 | 33.666657 | white | 14.898438 | 17 | 0.934937 | 0.910889 | 4 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 19 | 113 | 18.398438 | 105 | 35 | 38.59375 | 177.5 | 3.099609 | 1.5 | 0.599976 | 138 | 7.419922 | 86 | 48 | 3,700 | null | 2 | no(M2 and SIP pres) | 2 |
6,750 | 73.08997 | 1 | female | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 26,275 | 16,161.6875 | 22,394.9062 | 55 | white | 35.398438 | 83 | 0.385986 | 0.267944 | 1 | 0 | 0 | yes | 0.5 | 0.5 | dnr after sadm | 5 | 62 | 6.799805 | 65 | 10 | 35 | 596 | 2.899902 | 1.299805 | 0.599976 | 135 | 7.389648 | 183 | 12 | 713 | null | null | <2 mo. follow-up | 2.230469 |
6,751 | 63.51297 | 1 | male | 1 | 25 | 25 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 11 | under $11k | 0 | 73,398 | 39,047.5625 | 47,272.9375 | 38.75 | white | 21.898438 | 36 | 0.838989 | 0.784912 | 1 | 0 | 0 | no | 0.5 | 0.2 | dnr after sadm | 25 | 115 | 11 | 65 | 48 | 38.5 | 170 | null | 0.5 | 0.799927 | 131 | 7.40918 | 144 | 16 | 6,820 | null | 0 | <2 mo. follow-up | 0 |
6,752 | 51.431 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | $25-$50k | 9 | 42,284 | 26,786.9375 | 36,208.5938 | 58 | white | 31.898438 | 52 | 0.699951 | 0.609985 | 1 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 11 | 113 | 7.599609 | 95 | 16 | 36.29688 | null | null | 1.699951 | 0.599976 | 130 | null | 193 | 25 | null | null | 0 | <2 mo. follow-up | 0 |
6,753 | 59.34598 | 0 | female | 0 | 11 | 1,076 | CHF | COPD/CHF/Cirrhosis | 2 | 11 | $11-$25k | 0 | 12,036 | 7,768.1016 | 8,758.36719 | 19.5 | white | 22.898438 | 36 | 0.846924 | 0.747925 | 1 | 1 | 0 | no | 0.8 | 0.75 | no dnr | 11 | 131 | 8.699219 | 55 | 20 | 36.19531 | 253.03125 | null | null | 2.799805 | 144 | 7.389648 | 84 | 49 | 800 | 0 | 0 | no(M2 and SIP pres) | 0 |
6,754 | 78.448 | 1 | male | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 2 | 12 | null | 26 | 4,403 | 2,999.4981 | 3,697.06836 | 17 | white | 27.597656 | 44 | 0.383972 | 0.264954 | 1 | 0 | 0 | metastatic | 0 | 0 | dnr before sadm | -1 | 96 | 5.399414 | 126 | 24 | 38.29688 | 266.625 | 3.199707 | null | 1.199951 | 142 | 7.439453 | 90 | 44 | 1,350 | null | null | <2 mo. follow-up | 4.75293 |
6,755 | 52.189 | 1 | male | 0 | 3 | 284 | Lung Cancer | Cancer | 1 | 5 | $25-$50k | 0 | 3,155 | 2,068.5938 | 2,488.80859 | 8 | white | 14.599609 | 3 | 0.776978 | 0.535889 | 1 | 0 | 0 | metastatic | 1 | 0.6 | no dnr | 3 | 74 | 7.699219 | 72 | 20 | 38.5 | null | null | null | 0.799927 | 130 | null | 103 | 12 | 1,550 | 2 | 1 | no(M2 and SIP pres) | 1 |
6,756 | 66.62 | 1 | female | 0 | 3 | 217 | CHF | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 2,313 | 1,624.4463 | 1,960.05957 | null | white | 16.796875 | 36 | 0.887939 | 0.812988 | 1 | 1 | 0 | no | null | null | no dnr | 3 | 115 | 11.798828 | 60 | 10 | 36.59375 | 215 | 3.099609 | null | 0.699951 | 132 | 7.449219 | 189 | 16 | 5,230 | 0 | 1 | no(M2 and SIP pres) | 1 |
6,757 | 53.43698 | 1 | male | 0 | 4 | 295 | CHF | COPD/CHF/Cirrhosis | 5 | 10 | under $11k | 0 | 4,110 | 2,725.1269 | 2,844.35938 | 8 | white | 18.796875 | 21 | 0.900879 | 0.832886 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 4 | 107 | 8.798828 | 115 | 22 | 37.89844 | 218.5 | null | null | 0.599976 | 128 | 7.399414 | 116 | 4 | 2,275 | 0 | null | no(M2 and SIP pres) | 0.494751 |
6,758 | 75.01697 | 0 | female | 0 | 18 | 1,074 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 7 | under $11k | 0 | 27,437 | 18,642.6875 | 21,513.1875 | 24.666656 | white | 30.898438 | 42 | 0.633911 | 0.531982 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 18 | 72 | 0.099991 | 145 | 36 | 35.59375 | 250 | null | 0.399963 | 1.199951 | 136 | 7.439453 | 185 | 61 | 3,070 | 3 | 3 | no(M2 and SIP pres) | 3 |
6,759 | 37.34998 | 0 | male | 0 | 68 | 1,073 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 205,034 | 133,860.375 | 153,891.25 | 49.75 | white | 29 | 42 | 0.814941 | 0.75293 | 2 | 1 | 0 | no | null | null | no dnr | 68 | 62 | 14.199219 | 120 | 34 | 38.29688 | 240 | null | null | 2.299805 | 144 | 7.419922 | 308 | 83 | 4,245 | null | null | null | 3.105957 |
6,760 | 63.439 | 0 | female | 0 | 12 | 1,073 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | $11-$25k | 0 | 23,836 | 16,231.2422 | 18,787.2188 | 27.5 | white | 36.796875 | 76 | 0.510986 | 0.393982 | 3 | 0 | 0 | no | 0.2 | 0.15 | dnr after sadm | 1 | 78 | 4.799805 | 80 | 6 | 36.39844 | 306.625 | null | 1.199951 | 0.599976 | 141 | 7.439453 | 148 | 7 | 6,310 | 0 | 1 | SIP>=30 | 1 |
6,761 | 69.32794 | 1 | female | 0 | 3 | 411 | Lung Cancer | Cancer | 1 | 11 | under $11k | 0 | 4,540 | 3,229.625 | 3,698.38867 | null | white | 13.298828 | 14 | 0.765991 | 0.516968 | 1 | 0 | 0 | metastatic | 0.99 | 0.95 | no dnr | 3 | 63 | 7.099609 | 75 | 28 | 36.09375 | null | 3.699707 | 1 | 3.199707 | 143 | null | 84 | 75 | 2,400 | 1 | 2 | no(M2 and SIP pres) | 2 |
6,762 | 59.86298 | 1 | female | 1 | 11 | 11 | MOSF w/Malig | ARF/MOSF | 2 | 10 | $25-$50k | 9 | 37,759 | 23,176.9375 | 29,808.2188 | 51 | white | 46.296875 | 93 | 0.044998 | 0.014 | 1 | 0 | 0 | metastatic | 0.15 | 0.1 | no dnr | 11 | 105 | 4.899414 | 140 | 40 | 38.19531 | 176.65625 | null | 7.5 | 0.599976 | 135 | 7.489258 | 115 | 11 | 2,860 | null | 4 | <2 mo. follow-up | 4 |
6,763 | 77.45697 | 1 | male | 1 | 27 | 27 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | $11-$25k | 0 | 91,649 | 56,680.8438 | 64,669.3125 | 44.25 | white | 35 | 77 | 0.487976 | 0.369995 | 2 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 27 | 77 | 5.399414 | 59 | 20 | 35.89844 | null | null | 0.599976 | 1.099854 | 138 | null | 80 | 15 | null | null | 0 | <2 mo. follow-up | 0 |
6,764 | 66.73798 | 1 | male | 0 | 10 | 397 | CHF | COPD/CHF/Cirrhosis | 2 | 10 | $11-$25k | 0 | 9,034 | 6,444.5742 | 7,167.75781 | 19 | white | 24.796875 | 47 | 0.795898 | 0.671997 | 1 | 0 | 0 | no | 0.5 | 0.2 | no dnr | 10 | 130 | 13.099609 | 65 | 10 | 36.5 | 356.625 | null | 0.599976 | 1.299805 | 138 | 7.339844 | 256 | 11 | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,765 | 35.35699 | 1 | male | 0 | 17 | 490 | MOSF w/Malig | ARF/MOSF | 2 | 12 | >$50k | 0 | 58,401 | 38,772.9062 | 48,513.0938 | 24 | white | 29.296875 | 35 | 0.519897 | 0.403992 | 16 | 0 | 0 | yes | 1 | 0.8 | no dnr | 17 | 97 | 4.799805 | 52 | 16 | 37.79688 | null | null | 0.599976 | 1.399902 | 139 | null | 103 | 19 | 3,120 | 0 | 0 | no(M2 and SIP pres) | 0 |
6,766 | 40.94498 | 1 | male | 0 | 13 | 77 | Lung Cancer | Cancer | 2 | 12 | $11-$25k | 0 | 15,632 | 10,662.7188 | 13,903.7266 | 14 | black | 33.195313 | 20 | 0.360962 | 0.079987 | 1 | 0 | 0 | metastatic | 1 | 0.6 | no dnr | 13 | 79 | 14.298828 | 140 | 24 | 36.19531 | 357.125 | 2.599609 | 0.799927 | 1.899902 | 135 | 7.439453 | 182 | 24 | 1,700 | 1 | 0 | no(M2 and SIP pres) | 0 |
6,767 | 81.38495 | 1 | male | 0 | 4 | 283 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 3,165 | 2,084.1113 | 2,268.95898 | 9 | white | 19.597656 | 25 | 0.779907 | 0.647949 | 1 | 1 | 0 | no | 0.75 | 0.7 | no dnr | 4 | 65 | null | 105 | 10 | 37.59375 | 145 | 1.599854 | null | 3.199707 | 138 | 7.439453 | 99 | 39 | 1,105 | 0 | null | no(M2 and SIP pres) | 0.494751 |
6,768 | 80.21899 | 1 | male | 0 | 26 | 28 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 9 | 85,205 | 56,216.3125 | 66,549.5625 | 40 | hispanic | 35 | 57 | 0.110992 | 0.021999 | 10 | 1 | 0 | no | null | null | dnr after sadm | 13 | 62 | 5.799805 | 115 | 31 | 37.69531 | 142.5 | 2.099609 | 0.799927 | 0.699951 | 136 | 7.479492 | 115 | 11 | 3,090 | null | 0 | <2 mo. follow-up | 0 |
6,769 | 64.13995 | 1 | male | 0 | 31 | 435 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 10 | $25-$50k | 9 | 73,708 | 50,837.7188 | 55,910.75 | 20 | white | 29.5 | 48 | 0.60498 | 0.497986 | 11 | 1 | 0 | no | 0.75 | 0.5 | no dnr | 31 | 52 | 6.299805 | 125 | 24 | 36.19531 | null | null | 1.599854 | 1.399902 | 133 | null | 100 | 15 | 3,540 | 0 | 0 | SIP>=30 | 0 |
6,770 | 41.383 | 1 | male | 0 | 7 | 519 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 17,069 | 10,756.2969 | 11,814.9844 | 15.5 | white | 20.796875 | 22 | 0.892944 | 0.85498 | 2 | 0 | 0 | no | 1 | 1 | no dnr | 7 | 103 | 5.699219 | 120 | 24 | 36.59375 | null | 3.799805 | 0.399963 | 0.799927 | 135 | null | 120 | 4 | 925 | 5 | 4 | SIP>=30 | 4 |
6,771 | 66.28595 | 1 | male | 1 | 8 | 8 | Coma | Coma | 3 | 18 | under $11k | 0 | 25,847 | 16,392.5469 | 18,955.9375 | 34.5 | white | 31.398438 | 55 | 0.430969 | 0.357971 | 4 | 1 | 0 | no | 0.05 | 0.05 | dnr after sadm | 5 | 127 | 20.199219 | 96 | 20 | 36.59375 | 428 | null | null | 3.599609 | 132 | 7.239258 | 132 | 87 | null | null | 0 | <2 mo. follow-up | 0 |
6,772 | 54.12198 | 1 | male | 0 | 11 | 278 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 11,246 | 8,049.043 | 9,389.75781 | 5 | white | 20.5 | 36 | 0.813965 | 0.698975 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 11 | 83 | 4.599609 | 72 | 16 | 36.79688 | null | 3.899902 | 0.799927 | 1 | 137 | null | 113 | 9 | 6,000 | 0 | null | no(M2 and SIP pres) | 0.494751 |
6,773 | 60.69299 | 0 | female | 0 | 17 | 1,062 | MOSF w/Malig | ARF/MOSF | 3 | 13 | $11-$25k | 100 | 35,867 | 25,898.4531 | 31,090.9219 | 18 | black | 16.097656 | 21 | 0.246979 | 0.143982 | 21 | 0 | 0 | metastatic | 0.2 | 0.1 | dnr after sadm | 5 | 0 | 10.199219 | 70 | 22 | 36.59375 | 142 | null | 0.799927 | 2.099609 | 133 | 7.40918 | 98 | 38 | 2,170 | null | 7 | adl>=4 (>=5 if sur) | 7 |
6,774 | 73.76599 | 1 | male | 1 | 17 | 17 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 44 | 132,628 | 85,909.3125 | 101,108.5 | 48.666657 | white | 35.5 | 49 | 0.014 | 0.001 | 24 | 0 | 0 | yes | 0.8 | 0.6 | dnr after sadm | 9 | 137 | 14.798828 | 59 | 12 | 36.29688 | 145 | null | null | 0.799927 | 123 | 7.479492 | 157 | 29 | 1,845 | null | 0 | <2 mo. follow-up | 0 |
6,775 | 51.52399 | 0 | female | 0 | 13 | 1,060 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 18,329 | 12,042.0703 | 14,566.8984 | 14 | white | 17 | 20 | 0.912964 | 0.852905 | 1 | 0 | 0 | yes | 1 | 1 | no dnr | 13 | 68 | 6.099609 | 115 | 20 | 37.79688 | 324 | null | 0.799927 | 0.699951 | 137 | 7.439453 | 132 | 6 | 2,450 | 4 | 4 | SIP>=30 | 4 |
6,776 | 74.51099 | 1 | male | 0 | 6 | 18 | Colon Cancer | Cancer | 3 | 6 | under $11k | 0 | 7,807 | 5,308.9805 | 5,546.04688 | 17 | white | 28 | 34 | 0.576904 | 0.255981 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | dnr after sadm | 1 | 110 | 6.899414 | 100 | 24 | 37.5 | null | null | 0.699951 | 0.699951 | 138 | null | 105 | 14 | 6,500 | 5 | 4 | <2 mo. follow-up | 4 |
6,777 | 52.58899 | 0 | male | 0 | 11 | 1,060 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 18 | >$50k | 0 | 50,177 | 28,641.6406 | 33,983.2812 | 35 | white | 22.796875 | 22 | 0.809937 | 0.745972 | 16 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 11 | 62 | 21.199219 | 70 | 27 | 36.39844 | 132 | null | 0.5 | 0.799927 | 145 | 7.5 | 228 | 27 | 1,180 | 1 | 0 | no(M2 and SIP pres) | 0 |
6,778 | 70.21997 | 0 | male | 0 | 5 | 1,059 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 5,102 | 3,456.8359 | 4,135.29688 | 17 | black | 9.699219 | 16 | 0.92688 | 0.875977 | 1 | 0 | 0 | no | 0.98 | 0.98 | no dnr | 5 | 68 | 6.199219 | 125 | 30 | 36.59375 | 122.21875 | null | null | 3 | 136 | 7.319336 | 118 | 57 | 1,525 | 0 | null | null | 0.494751 |
6,779 | 74.19598 | 0 | male | 0 | 21 | 1,057 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | under $11k | 0 | 62,839 | 35,514.8438 | 42,219.5312 | 18.666656 | white | 15.298828 | 17 | 0.865967 | 0.81897 | 3 | 1 | 0 | no | 0.85 | 0.75 | no dnr | 21 | 82 | 8.798828 | 96 | 24 | 37.19531 | 314.25 | 4 | 0.599976 | 1.199951 | 141 | 7.479492 | 95 | 9 | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,780 | 45.60699 | 0 | male | 0 | 34 | 1,057 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | under $11k | 26 | 41,640 | 29,972.3125 | 32,769.6562 | 23.75 | black | 23.5 | 50 | 0.813965 | 0.751953 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 34 | 80 | null | 104 | 20 | 36.5 | 260 | null | 0.799927 | 1.099854 | 143 | 7.469727 | 143 | 16 | 987 | 5 | 5 | SIP>=30 | 5 |
6,781 | 82.85797 | 1 | female | 1 | 11 | 11 | CHF | COPD/CHF/Cirrhosis | 6 | 8 | under $11k | 0 | 10,010 | 7,016.332 | 7,759.61719 | 11 | white | 21.699219 | 38 | 0.723999 | 0.56897 | 1 | 0 | 0 | yes | 0.85 | 0.6 | no dnr | 11 | 99 | 8.199219 | 114 | 20 | 35.79688 | null | 2.799805 | 1.099854 | 4.099609 | 136 | null | 83 | 62 | 850 | null | 2 | <2 mo. follow-up | 2 |
6,782 | 69.83398 | 1 | female | 1 | 15 | 15 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 14 | $25-$50k | 55 | 54,848 | 35,273.5625 | 40,951.875 | 49.666657 | white | 30.199219 | 62 | 0.350952 | 0.233978 | 5 | 0 | 0 | no | 0.2 | 0 | dnr after sadm | 12 | 127 | 13.798828 | 150 | 12 | 38.79688 | 133.3125 | 2.399902 | 1 | 1.299805 | 146 | 7.369141 | 148 | 20 | 2,645 | null | 3 | <2 mo. follow-up | 3 |
6,783 | 60.98297 | 1 | female | 0 | 14 | 97 | Colon Cancer | Cancer | 1 | 10 | null | 0 | 14,493 | 10,190.1797 | 13,020.5078 | 16.666656 | white | 26.199219 | 26 | 0.664917 | 0.362976 | 1 | 0 | 0 | metastatic | 0.6 | 0.4 | no dnr | 14 | 132 | 16.097656 | 118 | 34 | 38.5 | 63.32812 | 2.5 | 6.199219 | 3.5 | 136 | 7.549805 | 251 | 36 | 218 | 3 | 0 | SIP>=30 | 0 |
6,784 | 48.08197 | 1 | male | 0 | 5 | 147 | MOSF w/Malig | ARF/MOSF | 1 | 18 | >$50k | 0 | 6,724 | 4,564.9688 | 5,882.49609 | 24 | white | 25.097656 | 30 | 0.697998 | 0.60791 | 1 | 0 | 0 | yes | 0.8 | 0.6 | no dnr | 5 | 108 | null | 70 | 20 | 35.59375 | 448 | 3.899902 | 0.5 | 3.199707 | 138 | 7.40918 | 99 | 64 | 850 | 0 | 0 | no(M2 and SIP pres) | 0 |
6,785 | 59.81097 | 1 | male | 1 | 9 | 9 | Coma | Coma | 3 | 4 | under $11k | 26 | 78,194 | 48,746.3438 | 56,834.1562 | 57 | hispanic | 36 | 68 | 0.169983 | 0.11499 | 21 | 1 | 0 | no | 0.25 | 0.1 | no dnr | 9 | 105 | 20.097656 | 114 | 12 | 40.59375 | 415 | 4.299805 | 0.599976 | 2 | 147 | 7.639648 | 402 | 56 | 1,350 | null | 0 | <2 mo. follow-up | 0 |
6,786 | 28.112 | 0 | male | 0 | 14 | 1,055 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 100 | 24,992 | 16,218.3984 | 18,223.0469 | 15.666664 | white | 22.296875 | 21 | 0.680908 | 0.587891 | 1 | 0 | 0 | no | 0.95 | 1 | no dnr | 14 | 72 | 4.799805 | 79 | 20 | 35.59375 | null | null | 0.5 | 2.299805 | 137 | null | 99 | 45 | 3,535 | null | 1 | SIP>=30 | 1 |
6,787 | 64.85999 | 0 | male | 0 | 40 | 1,055 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 44 | 110,427 | 72,151 | 83,565.1875 | 51.5 | white | 21.597656 | 37 | 0.675903 | 0.581909 | 4 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 40 | 71 | 11.099609 | 106 | 6 | 36.19531 | 140 | null | null | 2.299805 | 121 | 7.419922 | 611 | 50 | 1,175 | null | 1 | no(M2 and SIP pres) | 1 |
6,788 | 55.38098 | 1 | female | 0 | 6 | 106 | COPD | COPD/CHF/Cirrhosis | 3 | 10 | under $11k | 0 | 6,525 | 4,105.5742 | 4,464.85938 | 11 | white | 22.5 | 32 | 0.879883 | 0.800903 | 1 | 1 | 0 | no | 0.7 | 0.4 | no dnr | 6 | 92 | 10.699219 | 114 | 22 | 37.09375 | 134.6875 | 3.399902 | 0.199982 | 0.899902 | 137 | 7.299805 | 152 | 35 | null | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
6,789 | 62.327 | 1 | male | 0 | 7 | 75 | COPD | COPD/CHF/Cirrhosis | 6 | 8 | under $11k | 0 | 9,241 | 5,891.6875 | 6,155.33984 | 14 | white | 22.296875 | 47 | 0.815918 | 0.700928 | 1 | 0 | 0 | yes | 0.9 | 0.8 | dnr after sadm | 2 | 48 | 13.699219 | 147 | 28 | 38 | 240 | 1.699951 | 0.599976 | 5.199219 | 151 | 7.349609 | 104 | 102 | 2,010 | 0 | 1 | no(M2 and SIP pres) | 1 |
6,790 | 59.03598 | 1 | male | 0 | 7 | 204 | Lung Cancer | Cancer | 2 | 9 | under $11k | 0 | 5,416 | 4,056.1523 | 4,298.13672 | 7.5 | black | 21.097656 | 36 | 0.635986 | 0.325989 | 1 | 0 | 0 | metastatic | 0.6 | 0.5 | no dnr | 7 | 69 | 24.097656 | 129 | 22 | 38.09375 | 115 | 2.899902 | 1.799805 | 1.199951 | 145 | 7.5 | 365 | 42 | 3,327 | 2 | 4 | SIP>=30 | 4 |
6,791 | 84.53699 | 1 | female | 0 | 14 | 79 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 5 | null | 44 | 12,444 | 8,894.4688 | 10,864.3828 | 9.333328 | white | 30.5 | 53 | 0.369995 | 0.251953 | 1 | 0 | 1 | no | 0 | 0 | dnr after sadm | 1 | 103 | 8.798828 | 80 | 20 | 36.19531 | null | null | 0.399963 | 1.299805 | 131 | null | 300 | 28 | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
6,792 | 44.931 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 11 | under $11k | 0 | 37,033 | 25,186.625 | 31,456.5469 | 46 | hispanic | 37.796875 | 82 | 0.448975 | 0.329956 | 22 | 1 | 0 | yes | null | null | no dnr | 5 | 60 | 13.199219 | 61 | 28 | 36.19531 | 195 | 2.599609 | 1.099854 | 0.5 | 134 | 7.359375 | 94 | 16 | 1,490 | 0 | 2 | <2 mo. follow-up | 2 |
6,793 | 72.02496 | 1 | female | 0 | 49 | 735 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 112,799 | 74,849.375 | 85,010.1875 | 34.25 | white | 16.097656 | 22 | 0.817993 | 0.756958 | 5 | 0 | 0 | yes | null | null | no dnr | 49 | 105 | 24.5 | 114 | 24 | 36.39844 | 214.8125 | 4.299805 | 0.699951 | 0.799927 | 138 | 7.429688 | 348 | 19 | 2,300 | null | null | adl>=4 (>=5 if sur) | 2.364746 |
6,794 | 50.461 | 1 | female | 0 | 10 | 730 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 6 | under $11k | 0 | 26,216 | 17,106.7031 | 19,763.375 | 31 | hispanic | 25.296875 | 39 | 0.79895 | 0.73291 | 6 | 1 | 0 | no | null | null | no dnr | 10 | 24 | 17.5 | 0 | 34 | 38.39844 | 77 | 3.099609 | 0.799927 | 2 | 132 | 7.359375 | 199 | 33 | 129 | null | null | no(M2 and SIP pres) | 3.335938 |
6,795 | 62.724 | 1 | female | 0 | 14 | 117 | MOSF w/Malig | ARF/MOSF | 1 | 14 | under $11k | 0 | 19,549 | 12,885.7266 | 15,295.1328 | 22.666656 | black | 30.199219 | 54 | 0.554932 | 0.442993 | 1 | 0 | 0 | yes | 0.95 | 0.8 | no dnr | 14 | 71 | 13.199219 | 79 | 20 | 36.79688 | null | 2.5 | 22 | 0.699951 | 132 | null | 339 | 5 | null | 2 | 0 | no(M2 and SIP pres) | 0 |
6,796 | 30.24199 | 0 | male | 0 | 21 | 1,043 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 9 | 41,209 | 26,259.5 | 30,153.75 | 39.666657 | black | 35.195313 | 41 | 0.733887 | 0.651978 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 21 | 70 | 7.199219 | 67 | 10 | 38.89844 | 222.5 | 2.299805 | 1 | 1.199951 | 133 | 7.419922 | 115 | 10 | 3,270 | null | 7 | adl>=4 (>=5 if sur) | 7 |
6,797 | 74.47797 | 1 | female | 0 | 24 | 271 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 9 | 31,667 | 21,269.9531 | 25,303 | 29.333328 | white | 33.398438 | 54 | 0.532959 | 0.417969 | 1 | 0 | 0 | no | 0.25 | 0.2 | dnr before sadm | 0 | 147 | 63.796875 | 157 | 34 | 40.19531 | 94 | 2.399902 | 1.299805 | 0.599976 | 134 | 7.369141 | 184 | 23 | 1,870 | null | 7 | adl>=4 (>=5 if sur) | 7 |
6,798 | 63.56198 | 1 | female | 0 | 14 | 546 | MOSF w/Malig | ARF/MOSF | 1 | 16 | $11-$25k | 0 | 13,988 | 10,064.0312 | 12,720.2656 | 12 | white | 22.597656 | 10 | 0.666992 | 0.570923 | 1 | 0 | 0 | metastatic | 0.85 | 0.6 | no dnr | 14 | 61 | 19.5 | 118 | 29 | 38 | 206.65625 | 3.599609 | 0.599976 | 1.199951 | 137 | 7.449219 | 89 | 18 | 560 | 7 | 6 | SIP>=30 | 6 |
6,799 | 50.05099 | 1 | male | 1 | 56 | 56 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 120,445 | 81,407.6875 | 96,743.5 | 35.5 | white | 30.898438 | 48 | 0.454956 | 0.335999 | 12 | 0 | 0 | yes | 0.75 | 0.6 | dnr after sadm | 25 | 105 | 8.099609 | 122 | 30 | 36.89844 | 132.5 | 3 | 13.398438 | 1.099854 | 137 | 7.339844 | 109 | 42 | 2,155 | 0 | 0 | <2 mo. follow-up | 0 |
6,800 | 70.60596 | 1 | female | 0 | 100 | 130 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 15 | under $11k | 9 | 148,396 | 98,204.875 | 117,362.125 | 38 | black | 32.898438 | 79 | 0.546997 | 0.43396 | 2 | 1 | 0 | no | 0.3 | 0.3 | dnr after sadm | 11 | 105 | 8.398438 | 118 | 16 | 35.59375 | 273.3125 | 3.299805 | 1.199951 | 1 | 135 | 7.459961 | 214 | 32 | 2,935 | null | 7 | adl>=4 (>=5 if sur) | 7 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.